Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus

Journal of Diabetes and its Complications

Volumn 12, Issue 5, 1998, Pages 264-272

  Pelikánová, Terezie ^a,b   Pinsker, Přemysl ^a   Smrčková, Ivana ^a   Stříbrná, Ludmila ^a   Dryáková, Marie ^c  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b IPVZ   (Czech Republic)

^c INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ALDOSTERONE; FUROSEMIDE; GLUCOSE; INULIN; SODIUM; TISSUE KALLIKREIN;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KALLIKREIN URINE LEVEL; KIDNEY BLOOD FLOW; MALE; NATRIURESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SODIUM URINE LEVEL;

ADULT; BASAL METABOLISM; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIURETICS; FUROSEMIDE; GLOMERULAR FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HEMODYNAMIC PROCESSES; HUMANS; HYPERGLYCEMIA; KALLIKREINS; MALE; RENAL CIRCULATION; SODIUM; VASCULAR RESISTANCE;

EID: 0344906114     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(98)00002-6     Document Type: Article

References (52)

1. Mogensen C.E. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest. 28:1971;91-100.
2. Hostetter T.H., Rennke H.G., Brenner B.M. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 72:1982;375-380.
3. Mogensen C.E., Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 311:1984;89-93.
4. Feldt-Rasmussen B., Mathiesen E.R., Deckert T., Giese J., Christensen N.J., Bent-Hansen L., Nielsen M.D. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and cetacholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 30:1987;610-617.
5. Brochner-Mortensen J., Stockel M., Sorensen P.J., Nielsen A.H., Ditzel J. Proximal glomerulotubular balance in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 27:1984;189-192.
6. Körner A., Eklöf A.-C., Celsi G., Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes. 43:1994;629-633.
7. Margolius H.S. Kallikreins and kinins. Molecular characteristics and cellular and tissue responses. Diabetes. 45:1996;S14-S19.
8. Mayfield R.K., Shimojo N., Jaffa A.A. Skeletal muscle kallikrein. Potential role in metabolic regulation. Diabetes. 45:1996;S20-S23.
9. Cherry P.D., Furchgott R.F., Zawadzki J.V., Jothianandan D. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA. 79:1982;2106-2110.
10. Lahera V., Salom M.G., Fiksen-Olsen M.J., Romero J.C. Mediatory role of endothelium derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am J Hypertens. 4:1991;260-262.
11. Briner V.A., Tsai P., Schrier R.W. Bradykinin. potential for vascular constriction in the presence of endothelial injury Am J Physiol. 264:1993;F322-F327.
12. DeFelice A.F., Brousseau A. Natriuretic and vasodilating activities of intrarenally administered atriopeptin II, substance P and bradykinin in the dog. J Pharmacol Exp Ther. 246:1988;183-188.
13. Willis L.R. Effect of bradykinin on the renal medullary osmotic gradient in water diuresis. Eur J Pharmacol. 45:1977;173-183.
14. Lortie M., Regoli D., Rhaleb N.-E., Plante G.E. The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Physiol. 262:1992;R72-R76.
15. Jaffa A.A., Harvey J.N., Sutherland S.E., Margolius H.S., Mayfield R.K. Renal kallikrein responses to dietary protein. A possible mediator of hyperfiltration Kidney Int. 36:1989;1003-1010.
16. Saitoh S., Scicli A.G., Peterson E., Carretero O.A. Effect of inhibiting renal kallikrein on prostaglandin E2, water, and sodium excretion. Hypertension. 25:1994;1008-1013.
17. Nakagawa M., Stewart J.M., Vavrek R.J., Nasjletti A. Effects of a kinin antagonists on renal function in rats. Am J Physiol. 258:1990;F643-F648.
18. Mayfield R.K., Margolius H.S., Bailey G.S., Miller D.H., Sens D.A., Squires J., Namm D.H. Urinary and renal tissue kallikrein in the streptozotocin-diabetic rat. Diabetes. 34:1985;22-28.
19. Jaffa A.A., Miller D.H., Bailey G.S., Chao J., Margolius H.S., Mayfield R.K. Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on pro-kallikrein synthesis and activation. J Clin Invest. 80:1987;1651-1659.
20. Jaffa A.A., Chai K.X., Chao J., Mayfield R.K. Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kidney Int. 41:1992;789-795.
21. Harvey J.N., Jaffa A.A., Margolius H.S., Mayfield R.K. Renal kallikrein and hemodynamic abnormalities of diabetic kidney. Diabetes. 39:1990;299-304.
22. Jaffa A.A., Rust P.F., Mayfield R.K. Kinin, a mediator of diabetes-induced glomerular hyperfiltration. Diabetes. 44:1995;156-160.
23. Manto A., Cotroneo P., Porcelli G., D'Errico G.D., Marra G., Magnani P., Tilli P., Greco A.V., Ghirlanda G. Urinary kallikrein excretion in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 36:1993;423-427.
24. Harvey J.N., Edmundson A.W., Jaffa A.A., Martin L.L., Mayfield R.K. Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function. Diabetologia. 35:1992;857-862.
25. Mayfield R.K., Margolius H.S., Levine J.H., Wohltmann H.J., Loadholt C.B., Colwell J.A. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. J Clin Endocrinol Metab. 59:1984;278-286.
26. Baba T., Murabayashi S., Ishizaki T., Ido Y., Aoyagi K., Takeba K. Renal kallikrein in diabetic patients with hypertension accompanied by nephropathy. Diabetologia. 29:1986;162-167.
27. Greco A.V., Porcelli G., Di Iorio M., Ranieri M., D'Acquarica L., Ranalli L. Altered urinary excretion of human kinase activity in hypertension. Adv Exp Med Biol. 120B:1979;45-649.
28. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique. A method for quantifying insulin secretion and resistance Am J Physiol. 237:1979;E214-E223.
29. Keilacher H., Besch W., Woltanski K.P., Diaz-Alonso J.M., Kohnert K.D., Ziegler M. Determination of free and total insulin. Correlations to insulin antibody levels. Exp Clin Endocrinol. 90:1987;271-277.
30. White R.P., Samson E.F. Determination of insulin in plasma and urine by use of anthrone. J Lab Clin Med. 43:1954;475-478.
31. Smith H.W., Finkelstein N., Aliminosa L., Crowford B., Groher M. Renal clearances of substituted hippuric acid derivates and other aromatic acids in dog and man. J Clin Invest. 24:1945;388-404.
32. Margolius H.S., Horwitz D., Geller R.G., Alexander R.W., Gill J.R., Pisano J.J., Keiser H.R. Urinary kallikrein excretion in normal man. Relationship to sodium intake and sodium-retaining steroids. Circ Res. 35:1974;812-819.
33. Haber E., Koerner T., Page L.B., Kliman B., Purnode A. Application of RIA for angiotensin I to the physiologic measurements of PRA in normal human subjects. J Clin Endocrinol Metab. 29:1969;1349-1355.
34. Murphy B.E.P. Non-chromatographic radiotransinassay for cortisol. Application to human adult serum, umbilical cord serum and amniotic fluid J Clin Endocrinol Metab. 41:1975;1050-1057.
35. Levy S.B., Lilley J.J., Frigon R.P., Stone R.A. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest. 60:1977;129-138.
36. Vora J.P., Oyama T.T., Thompson M.M., Anderson S. Interactions of renin-angiotensin (RAS) and kallikrein-kinin (KKS) systems in the diabetic kidney. Diabetes. 46:1997;107-112.
37. Komers R., Cooper M.E. Acute renal hemodynamic effects of angiotensin converting enzyme inhibition in diabetic hyperfiltration. the role of kinins Am J Physiol. 268:1995;F588-F594.
38. Allen T.J., Cao Z., Youssef S., Hulthen U.L., Cooper M.E. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies. Diabetes. 46:1997;1612-1618.
39. Tuttle K.R., Bruton J.L., Perusek M.C., Lancaster J.L., Kopp D.T., DeFronzo R.A. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med. 324:1991;1626-1632.
40. Skott P., Vaag A., Hother-Nielsen O., Andersen P., Bruun N.E., Giese J., Beck-Nielsen H., Parving H.H. Effects of hyperglycaemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest. 51:1991;715-727.
41. Christiansen J.S., Gammelgaard J., Frandsen M., Parving H.-H. Increased kidney size, glomerular filtration rate, and renal plasma flow in short-term insulin dependent diabetics. Diabetologia. 20:1981;4561-4566.
42. Remuzzi A., Viberti G.C., Ruggenenti P., Battaglia C., Pagni R., Remuzzi G. Glomerular response to hyperglycemia in human diabetic nephropathy. Am J Physiol. 259:1990;F545-F552.
43. DeCosmo S., Earle K., Morocutti A., Walker J., Ruggenenti P., Remuzzi G., Viberti G.C. Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients. Inhibition by acetylsalicylic acid infusion Diabetologia. 36:1993;622-627.
44. Christiansen J.S., Frandsen M., Parving H.H. Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia. 21:1981;368-373.
45. Mogensen C.E. Glomerular filtration rate and renal plasma flow in normal and diabetic man during elevation of blood sugar levels. Scand J Clin Lab Invest. 28:1971;177-182.
46. Mogensen C.E. Elevated glomerular filtration rate in insulin-treated short-term diabetes. Non-dependence on blood sugar value. Acta Med Scand. 194:1973;559-561.
47. Wiseman M.J., Mangili R., Alberetto M., Keen H., Viberti G.C. Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics. Kidney Int. 31:1987;1012-1018.
48. Allen T.J., Cooper M.E., O'Brien R.C., Bach L.A., Jackson B., Jerums G. Glomerular filtration rate in streptozotocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy. Diabetes. 39:1990;1182-1190.
49. Skott P., Hother-Nielsen O., Bruun N.E., Giese J., Nielsen M.D., Beck-Nielsen H., Parving H.H. Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia. 32:1989;694-699.
50. Stenvinkel P., Bolinder J., Alvestrand A. Effects of insulin on renal haemodynamics and the proximal and distal tubular sodium handling in healthy subjects. Diabetologia. 35:1992;1042-1048.
51. Siragy H.M., Ibrahim M.M., Jaffa A.A., Mayfield R., Margolius H.S. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3′,5′-monophosphate. Effects of altered sodium intake. Hypertension. 23:1994;1068-1070.
52. Scicli A.G., Carretero O.A. Renal kallikrein-kinin system. Kidney Int. 29:1986;120-130.